Tag Archives: Treatment

All about monoclonal antibody drugs — the experimental treatment that may have turned Trump’s COVID-19 around

Article content continued “It’s entirely possible that by the time you’re giving it, you’re giving it too late.” Medical technicians work at a drive-through COVID-19 testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, September 17, 2020. Photo by Brendan McDermid/Reuters/File That Trump got something wholly experimental has raised eyebrows, but… Read More »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma

Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to… Read More »

Trump to announce plasma treatment authorized for COVID-19

WASHINGTON — After expressing frustration at the slow pace of approval for coronavirus treatments, President Donald Trump was set to announce on Sunday the emergency authorization of convalescent plasma for COVID-19 patients. The announcement will come after days of White House officials suggesting there were politically motivated delays by the Food and Drug Administration in… Read More »